|

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

RECRUITINGN/ASponsored by M.D. Anderson Cancer Center
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2020-03-20
Est. completion2028-11-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04373720

Summary

This trial uses magnetic resonance elastography (MRE) to estimate tissue stiffness (hardness or softness of the tissue) in tissue that is affected by radiation treatment (radiation necrosis) and tumor tissue that has come back (recurrent) after treatment in patients with gliomas. Diagnostic procedures, such as MRE, may estimate the differences in tissue stiffness between radiation necrosis and recurrent glioma post treatment and ultimately lead to a more accurate diagnosis and/or surgery, and/or a better assessment of the disease's response to treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria

* \>/=18 years old.
* History of a pathology proven intracranial glioma (including IDH mutant, IDH wildtype or 1p19q co-deleted tumors) treated with chemotherapy and radiation.
* The lesion of concern (T2 Flair Hyperintense or contrast enhancing lesion) is \> 2 cm
* Patient is able to understand and give consent to participation in the study.

Exclusion Criteria

* Patients less than 18 years of age.
* Pregnant.
* Known allergy to gadolinium-based contrast agents.
* Renal failure as evidenced by a glomerular filtration rate (GFR) of less than 30 mL/min/1.73m2.
* Pacemakers, electronic stimulation, metallic foreign bodies and devices and/or other conditions that are not MR safe, which include but are not limited to:

  * electronically, magnetically, and mechanically activated implants
  * ferromagnetic or electronically operated active devices like automatic cardioverter defibrillators and cardiac pacemakers
  * metallic splinters in the eye
  * ferromagnetic hemostatic clips in the central nervous system (CNS) or body
  * cochlear implants
  * other pacemakers, e.g., for the carotid sinus
  * insulin pumps and nerve stimulators
  * non-MR safe lead wires
  * prosthetic heart valves (if dehiscence is suspected)
  * non-ferromagnetic stapedial implants
  * claustrophobia that does not readily respond to oral medication

Conditions2

CancerGlioma

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Melissa Chen, MD713-745-9789

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.